Literature DB >> 10405937

An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. Tri-Nation Study Group.

A E Clarke1, M A Petri, S Manzi, D A Isenberg, C Gordon, J L Senecal, Y St Pierre, L Joseph, J Penrod, P R Fortin, N Sutcliffe, J R Goulet, D Choquette, T Grodzicky, D S Danoff, V Ho, J M Esdaile.   

Abstract

OBJECTIVE: To compare health care expenditure and health status for patients with systemic lupus erythematosus (SLE) between nations with distinct mechanisms for funding and delivering health care services.
METHODS: Seven hundred eight patients with SLE from 2 centers in each of 3 countries (Canada 229, United States 268, United Kingdom 211) underwent physician assessment of disease activity and damage and reported on physical and psychosocial well being, satisfaction, social support, and health resource utilization. To compare overall utilization, constant prices (1997 Canadian dollars) were applied across countries for each service, enabling diverse resources to be collapsed into a single expression.
RESULTS: After adjusting for important patient covariates, Canadian, compared to American and British patients, reported significantly superior health status in 3 of 8 Medical Outcome Survey Short Form-36 (SF-36) subscales, the SF-36 physical component summary score, and the visual analog scale of general health status. There was no consistent trend in patient satisfaction. Overall annual resource utilization did not vary significantly, with mean annual per patient expenditures (adjusted for demographics, disease duration, activity, damage, social support, health status, patient satisfaction, and age and sex adjusted country-specific SF-36 general population norms) totalling $4853, $5285, and $4760 for Canada, US, and the UK, respectively. However, within each resource category, differences were observed. Canadians saw more specialists than the British, the British more generalists. Canadians and Americans were more frequent users of the emergency room; Americans of laboratory/imaging procedures. Canadians had higher hospital costs than Americans.
CONCLUSION: After adjustment, Canadian patients reported better well being than their counterparts. Despite considerable differences in the mechanisms of health care funding and service mixture, overall resource utilization did not vary significantly between the countries, although there was a trend towards more intense use of inpatient services in Canada and outpatient services in the United States.

Entities:  

Mesh:

Year:  1999        PMID: 10405937

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

1.  Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data.

Authors:  Eliza F Chakravarty; Thomas M Bush; Susan Manzi; Ann E Clarke; Michael M Ward
Journal:  Arthritis Rheum       Date:  2007-06

2.  Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries.

Authors:  A Boonen; D van der Heijde; R Landewé; A Spoorenberg; H Schouten; M Rutten-van Mölken; F Guillemin; M Dougados; H Mielants; K de Vlam; H van der Tempel; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

Review 3.  The humanistic and economic burden of systemic lupus erythematosus : a systematic review.

Authors:  Rachel Meacock; Nicola Dale; Mark J Harrison
Journal:  Pharmacoeconomics       Date:  2013-01       Impact factor: 4.981

4.  Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries.

Authors:  A Boonen; D van der Heijde; R Landewé; F Guillemin; M Rutten-van Mölken; M Dougados; H Mielants; K de Vlam; H van der Tempel; S Boesen; A Spoorenberg; H Schouten; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

5.  Direct medical costs and their predictors in South Korean patients with systemic lupus erythematosus.

Authors:  So-Yeon Park; Young Bin Joo; Jeeseon Shim; Yoon-Kyoung Sung; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2015-08-09       Impact factor: 2.631

6.  Health care in systemic lupus erythematosus (SLE): the patient's perspective.

Authors:  E J M Zirkzee; G M Steup-Beekman; A A Schouffoer; S M Henquet; M A A Caljouw; T W J Huizinga; T P M Vliet Vlieland
Journal:  Clin Rheumatol       Date:  2014-04-18       Impact factor: 2.980

7.  Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus.

Authors:  Pantelis Panopalis; Jinoos Yazdany; Joann Zell Gillis; Laura Julian; Laura Trupin; Aimee O Hersh; Lindsey A Criswell; Patricia Katz; Edward Yelin
Journal:  Arthritis Rheum       Date:  2008-12-15

Review 8.  The socioeconomic burden of SLE.

Authors:  Chak Sing Lau; Anselm Mak
Journal:  Nat Rev Rheumatol       Date:  2009-06-09       Impact factor: 20.543

Review 9.  Development of a Set of Lupus-Specific, Ambulatory Care-Sensitive, Potentially Preventable Adverse Conditions: A Delphi Consensus Study.

Authors:  Candace H Feldman; Cameron Speyer; Rachel Ashby; Bonnie L Bermas; Shamik Bhattacharyya; Eliza Chakravarty; Brendan Everett; Elizabeth Ferucci; Aimee O Hersh; Francisco M Marty; Joseph F Merola; Rosalind Ramsey-Goldman; Brad H Rovin; Mary Beth Son; Laura Tarter; Sushrut Waikar; Jinoos Yazdany; Joel S Weissman; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-01       Impact factor: 4.794

10.  Economic Evaluation of Lupus Nephritis in the Systemic Lupus International Collaborating Clinics Inception Cohort Using a Multistate Model Approach.

Authors:  Megan R W Barber; John G Hanly; Li Su; Murray B Urowitz; Yvan St Pierre; Juanita Romero-Diaz; Caroline Gordon; Sang-Cheol Bae; Sasha Bernatsky; Daniel J Wallace; David A Isenberg; Anisur Rahman; Ellen M Ginzler; Michelle Petri; Ian N Bruce; Paul R Fortin; Dafna D Gladman; Jorge Sanchez-Guerrero; Rosalind Ramsey-Goldman; Munther A Khamashta; Cynthia Aranow; Meggan Mackay; Graciela S Alarcón; Susan Manzi; Ola Nived; Andreas Jönsen; Asad A Zoma; Ronald F van Vollenhoven; Manuel Ramos-Casals; Guillermo Ruiz-Irastorza; S Sam Lim; Kenneth C Kalunian; Murat Inanc; Diane L Kamen; Christine A Peschken; Soren Jacobsen; Anca Askanase; Chris Theriault; Vernon Farewell; Ann E Clarke
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-08-17       Impact factor: 4.794

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.